ACM
ACT Capital Management Portfolio holdings
AUM
$72.5M
This Quarter Return
+9.62%
1 Year Return
-33.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$193M
AUM Growth
+$193M
(-0.85%)
Cap. Flow
+$391K
Cap. Flow
% of AUM
0.2%
Top 10 Holdings %
Top 10 Hldgs %
60.41%
Holding
141
New
24
Increased
23
Reduced
12
Closed
33
Top Buys
| 1 |
INmune Bio
INMB
|
$5.34M |
| 2 |
STAAR Surgical
STAA
|
$4.7M |
| 3 |
enVVeno Medical
NVNO
|
$2.73M |
| 4 |
IDEAYA Biosciences
IDYA
|
$2.66M |
| 5 |
Affirm
AFRM
|
$2.32M |
Top Sells
| 1 |
Cassava Sciences
SAVA
|
$3.85M |
| 2 |
Unity
U
|
$3.55M |
| 3 |
The Beauty Health Co
SKIN
|
$2.9M |
| 4 |
F5
FFIV
|
$2.71M |
| 5 |
Upstart Holdings
UPST
|
$2.44M |
Sector Composition
| 1 | Healthcare | 79.46% |
| 2 | Technology | 5.18% |
| 3 | Financials | 3.5% |
| 4 | Communication Services | 3.41% |
| 5 | Consumer Discretionary | 1.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $34.5M | 17.87% | 268,200 +36,600 | +16% | +$4.7M |
|
2
Arcturus Therapeutics
ARCT
$462M
| $21.8M | 11.27% | 455,300 | – | – |
|
3
Clearside Biomedical
CLSD
$28.9M
| $14.8M | 7.67% | 2,467,500 +5,000 | +0.2% | +$30K |
|
4
Arrowhead Research
ARWR
$3.05B
| $12.1M | 6.28% | 194,000 -14,600 | -7% | -$911K |
|
|
TRIL
5
DELISTED
Trillium Therapeutics Inc.
TRIL
| $8.18M | 4.24% | 466,000 +1,000 | +0.2% | +$17.6K |
|
6
fuboTV
FUBO
$1.21B
| $6.08M | 3.15% | 253,700 -14,300 | -5% | -$343K |
|
|
7
Upstart Holdings
UPST
$7.05B
| $5.41M | 2.8% | 17,100 -7,700 | -31% | -$2.44M |
|
|
8
INmune Bio
INMB
$54M
| $5.34M | 2.77% | +275,000 | New | +$5.34M |
|
|
9
IDEAYA Biosciences
IDYA
$2.15B
| $4.42M | 2.29% | 173,500 +104,300 | +151% | +$2.66M |
|
10
Aurinia Pharmaceuticals
AUPH
$1.58B
| $3.98M | 2.06% | 180,000 +17,500 | +11% | +$387K |
|
|
AWH
11
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $3.68M | 1.9% | 1,130,720 | – | – |
|
|
12
Affirm
AFRM
$28.8B
| $2.92M | 1.51% | 24,500 +19,500 | +390% | +$2.32M |
|
13
Nektar Therapeutics
NKTR
$568M
| $2.9M | 1.5% | 161,500 | – | – |
|
14
Natera
NTRA
$23.1B
| $2.89M | 1.5% | 25,900 | – | – |
|
|
15
enVVeno Medical
NVNO
$15.4M
| $2.73M | 1.41% | +262,500 | New | +$2.73M |
|
|
ICAD
16
DELISTED
iCAD Inc
ICAD
| $2.41M | 1.25% | 224,500 +2,500 | +1% | +$26.9K |
|
17
Atara Biotherapeutics
ATRA
$84.6M
| $2.09M | 1.08% | 116,900 | – | – |
|
18
Krystal Biotech
KRYS
$4.27B
| $2.09M | 1.08% | 40,000 +20,925 | +110% | +$1.09M |
|
|
NUAN
19
DELISTED
Nuance Communications, Inc.
NUAN
| $2.06M | 1.07% | 37,500 | – | – |
|
20
TG Therapeutics
TGTX
$4.65B
| $2M | 1.04% | 60,000 +5,000 | +9% | +$166K |
|
21
United Therapeutics
UTHR
$13.8B
| $1.94M | 1% | 10,500 | – | – |
|
22
Inhibikase Therapeutics
IKT
$134M
| $1.92M | 0.99% | 1,010,000 +135,000 | +15% | +$257K |
|
|
MYOV
23
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.91M | 0.99% | 85,000 -2,500 | -3% | -$56.1K |
|
|
AFMD
24
DELISTED
Affimed
AFMD
| $1.74M | 0.9% | 281,300 -6,300 | -2% | -$38.9K |
|
25
Neurogene
NGNE
$264M
| $1.73M | 0.9% | 239,000 | – | – |
|